skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Show More

Products

Show More

Show More

68 Total results for product and free and sample content found

Pharma R&D Annual Review 2018

17 Jun 2022

Pharma R&D Annual Review 2018

Authored for the last 25 years by Ian Lloyd, Senior Director of Pharmaprojects and Data Integration, this vital resource uses a music motif to turn up the volume on the evolution of trends in pharmaceutical R&D. Lloyd assesses industry trends by examining the pipeline by company, therapeutic area, disease, target, and drug type.

Topic research

Webinar Recording: Pharma R&D Review: What Changed In 2018, What To Look Out For In 2019

By Ian Lloyd 15 Jun 2022

April 17, 2019,  Pharma R&D Review: What Changed In 2018, What To Look Out For In 2019

Topic drug-approval research

Informa Pharma Intelligence Launches 30th Edition Pharma R&D Annual Review

24 Mar 2022

Informa Pharma Intelligence Launches 30th Edition Pharma R&D Annual Review

Pharmaprojects’ 2022 Report Highlights Breakthrough Trends in Pharmaceutical R&D

Topic research

Quick Listen: Scrip's Five Must-Know Things

By Ian Haydock 08 Dec 2020

Join us for a brief audio tour around the past week's major global biopharma industry developments, in this podcast version of Scrip's Five Must-Know Things

Topic Coronavirus vaccines research

HBW Insight

UK Researchers Seek Commercial Partner For Nasal Spray Shown To 'Prevent' COVID-19

29 Nov 2020

covid19 nasal spray R&D

A nasal spray formulated using compounds already approved by regulatory bodies in Europe and the US can “prevent and slow” transmission of COVID-19, according to UK researchers who are now seeking a partner to commercialize the product.

Topic Coronavirus research vaccines OTC Drugs

Quick Listen: Scrip's Five Must-Know Things

29 Nov 2020

Join us for a brief audio tour around the past week's key developments in the global biopharma industry, in this podcast version of Scrip's Five Must-Know Things

Topic Coronavirus research vaccines

Coronavirus Update: Roche's Actemra Fails In Phase III COVID Study

27 Nov 2020

Disappointment as Roche/Chugai antibody tocilizumab misses most endpoints. 

Topic Coronavirus Clinical Trials Research & Development

Coronavirus Update: After Rumors Of Shortcut To Market, AZ Pledges To 'Follow Science' In Vaccine Trials

By Scrip Team 27 Nov 2020

The company reiterates core values to 'follow the science' and 'put patients first' after talk of an emergency use authorization without completing Phase III trials.

Topic Coronavirus clinical-trials research

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.

Contact us for product technical and account support.

  • US Toll-Free   : +1 888 670 8900 
  • US Toll             : +1 212-600-3520
  • UK & Europe : +44 (0) 208 052 0700

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: